Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

0.5151 -0.0158 (-2.98%)
Streaming Delayed Price Updated: 12:43 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lexaria Bioscience Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Unusual volume stocks are being observed in Friday's session. 
Via Chartmill
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Which stocks are moving on Monday? ↗
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Which stocks are gapping on Monday? ↗
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Monday's pre-market session: top gainers and losers ↗
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Provides Strategic Update
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
Nasdaq Gains 100 Points; US Consumer Sentiment Falls ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.83% to 46,328.48 while the NASDAQ rose 0.45% to 22,484.92. The... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million. 
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Friday? ↗
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Friday's session: gap up and gap down stocks ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0.58% to 46,213.26 while the NASDAQ rose 0.31% to 22,455.17. The S&P 500 also... 
Via Benzinga
Topics Economy Stocks
News headline image
What's going on in today's pre-market session ↗
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket ↗
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Are Lexaria Bioscience Shares Soaring 45% After Hours? ↗
Lexaria Bioscience Corp. (NASDAQ: LEXX) experienced a dramatic 45.10% surge in after-hours trading on Thursday, climbing to $2.22 from its closing price of $1.53. 
Via Benzinga
News headline image
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
Via ACCESS Newswire
News headline image
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
Via ACCESS Newswire
News headline image
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
Via ACCESS Newswire
News headline image
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
Via ACCESS Newswire
News headline image
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.